Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Reconsideration of the heterogeneity of reactive glia in neurodegenerative diseases DAM heterogeneity and different roles In this section, we selected several recent studies addressing the issues discussed above
Long-term safety data continues to emerge for newer medications like tirzepatide
The training of HCPs and group GLP-1 RA start set ups needs careful thought and attention
raised a genuine regulatory problem in his interview with Joe Rogan that the AP had no appetite for engaging with fairly
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
